Role of gut-brain axis dysregulation in the pathogenesis of non-alcoholic fatty liver disease: mechanisms and therapeutic implications
American Journal of Translational Research · 2025 · 17 (5) · 3276-3292
DOI: 10.62347/zwsr4476 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Translational Research, 2025. Verfasst von Mei Wan und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of China Three Gorges University, Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, Yich…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Clinical Medical College of China Three Gorges University, Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, Yichang Central People's Hospital Yichang 443000, Hubei, China.
- Yichang Key Laboratory of Endocrinology Yichang 443000, Hubei, China.
- Life Science, Queen's University Kingston K7L 3N6, Ontario, Canada.
- Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University Changsha 410011, Hunan, China.
Zitieren
APA
Wan, M., Zhao, W., Cai, Y., He, Q., & Zeng, J. (2025). Role of gut-brain axis dysregulation in the pathogenesis of non-alcoholic fatty liver disease: mechanisms and therapeutic implications. American Journal of Translational Research, 17(5), 3276-3292. https://doi.org/10.62347/zwsr4476
Vancouver
Wan M, Zhao W, Cai Y, He Q, Zeng J. Role of gut-brain axis dysregulation in the pathogenesis of non-alcoholic fatty liver disease: mechanisms and therapeutic implications. American Journal of Translational Research. 2025;17(5):3276-3292. doi:10.62347/zwsr4476
BibTeX
@article{Wan2025,
author = {Wan, Mei and Zhao, Weimin and Cai, Yifan and He, Qian and Zeng, Jun},
title = {Role of gut-brain axis dysregulation in the pathogenesis of non-alcoholic fatty liver disease: mechanisms and therapeutic implications},
journal = {American Journal of Translational Research},
year = {2025},
volume = {17},
number = {5},
pages = {3276--3292},
doi = {10.62347/zwsr4476}
}
EUVIMED